TransMedics Group, Inc. - Common Stock (TMDX)

Historical Holders from Q1 2019 to Q3 2025

Symbol
TMDX on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
33.9M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
37.1M
Holdings value
$4.17B
% of all portfolios
0.005%
Grand Portfolio weight change
0%
Number of holders
384
Number of buys
220
Number of sells
-170
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TransMedics Group, Inc. - Common Stock (TMDX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +16.2% $468M $64.3M 5.06M +15.9% FMR LLC 31 Mar 2025
BlackRock, Inc. 14.6% $664M 4.96M BlackRock, Inc. 30 Jun 2025

Institutional Holders of TransMedics Group, Inc. - Common Stock (TMDX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 37.1M $4.17B -$10.7M $112.20 384
2025 Q2 36.8M $4.93B -$289M $134.01 366
2025 Q1 39M $2.63B +$166M $67.28 295
2024 Q4 36.9M $2.3B -$389M $62.35 308
2024 Q3 36.5M $5.72B +$61.4M $157.00 365
2024 Q2 33.7M $5.08B +$90M $150.62 331
2024 Q1 34M $2.52B -$71.3M $73.94 251
2023 Q4 35M $2.76B -$4.09M $78.93 244
2023 Q3 34.9M $1.91B +$75.7M $54.75 218
2023 Q2 32.5M $2.73B +$227M $83.98 238
2023 Q1 29.9M $2.26B +$69.3M $75.73 221
2022 Q4 29M $1.79B +$38.5M $61.72 196
2022 Q3 28.3M $1.18B +$229M $41.74 174
2022 Q2 22.9M $719M +$66.8M $31.45 129
2022 Q1 20.8M $561M +$24.7M $26.94 107
2021 Q4 20.1M $385M +$27.4M $19.16 116
2021 Q3 19.2M $636M +$13.3M $33.09 116
2021 Q2 18.8M $623M +$1.14M $33.18 117
2021 Q1 18.6M $773M -$21M $41.49 104
2020 Q4 21.3M $424M -$4.48M $19.90 67
2020 Q3 20.8M $287M +$6.19M $13.78 71
2020 Q2 20.2M $361M +$93M $17.92 68
2020 Q1 15.1M $182M -$2.05M $12.08 53
2019 Q4 15M $284M -$13.7K $19.01 59
2019 Q3 14.3M $337M +$4.71M $23.75 49
2019 Q2 11.2M $312M +$312M $28.99 59
2019 Q1 54 $2K $37.04 1